In cervical and ovarian cancers, the number of cells that express mesenchymal marker vimentin is inversely related to RCAS1 expression, as remodeling of stromal tissue by vimentin results in tumor invasion and metastasis[35]. Here, EBAG9 is linked to neoplasm.